ArticleCureus2023

Clinicopathological Features and Status of Programmed Death Ligand-1 (PD-L1) Expression in Lung Cancer: A Single Centre Study From North India.

Firdous Ganie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.